OpportunityTitle: Pediatric Phase 1/Pilot Consortium (Limited Competition UM1)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following: The eligibility to apply in response to this FOA is limited to the current recipient of the Children&apos;s Oncology Group Phase 1/Pilot Consortium award.
Description: The purpose of this Funding opportunity Announcement (FOA) is to continue the NCIs program for Pediatric Phase 1/Pilot Consortium. The function of the Consortium is to conduct Phase 1 and pilot studies in children with cancer so that new agents can be introduced into the pediatric oncology setting in a timely manner. The Consortium&apos;s ability to quickly conduct first in children studies is critical to NCIs overall clinical research program for children with cancer. To accomplish the objectives of the FOA, a strong multi-institutional, multi-disciplinary research team is needed that can rapidly and efficiently design and conduct Phase 1 and pilot clinical trials and that is experienced in doing so within the ethical constraints applicable to research involving children. The ultimate purpose for supporting the Pediatric Phase 1/Pilot Consortium is to improve therapy outcomes for children with cancer.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;